Back

What's in the IV iron trial pipeline and what will it add?

29 June 2021 (12:09 - 12:17)
Organised by:
Congress Presentation Part of: Iron deficiency and heart failure - evidence is piling up - what's next? Treatment Open Access Heart Failure 2021

About the speaker

Photo
Professor Paul Kalra

Portsmouth Hospitals NHS Trust, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Introduction and welcome.
Professor J. Cleland (Glasgow, GB)
Video
Presentation thumbnail
Functional and clinical outcomes with IV iron so far.
Professor P. Van Der Meer (Groningen, NL)
Video
Presentation thumbnail
Live Q&A.
Video
Presentation thumbnail
Recent evidence on ferric derisomaltose in heart failure.
Doctor A. Ambrosy (San Francisco, US)
Video
Presentation thumbnail
Live Q&A.

Access the full session

Session thumbnail
Iron deficiency and heart failure - evidence is piling up - what's next?
Video

The Event

Event poster

Heart Failure 2021

29 June 2021 12:09 CET
You may be interested in
thumbnail
Congress Session
IV iron – What is the current status and what are the future perspectives
18 May 2025
thumbnail
Congress Session
The new frontier in oral anticoagulation: Factor XIa inhibitors
16 April 2023
thumbnail
Congress Presentation
The IIISAS trial: a randomized controlled trial designed to assess the effect of ferric derisomaltose on physical capacity in patients with aortic stenosis and iron deficiency undergoing TAVI
29 June 2021
thumbnail
Congress Presentation
Discussant review - Effects of FCM on recurrent HF hospitalizations: an individual participant data meta-analysis
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources